BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daniel LL, Dickson AL, Chung CP. Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine. Clin Rheumatol 2021;40:65-73. [PMID: 32617765 DOI: 10.1007/s10067-020-05258-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Balevic SJ, Sagcal-Gironella ACP. Precision Medicine: Towards Individualized Dosing in Pediatric Rheumatology. Rheum Dis Clin North Am 2022;48:305-30. [PMID: 34798954 DOI: 10.1016/j.rdc.2021.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Dickson AL, Daniel LL, Zanussi J, Dale Plummer W, Wei WQ, Liu G, Reese T, Anandi P, Birdwell KA, Kawai V, Cox NJ, Dupont WD, Hung AM, Feng Q, Stein CM, Chung CP. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. Clin Pharmacol Ther 2021. [PMID: 34582038 DOI: 10.1002/cpt.2428] [Reference Citation Analysis]
3 Stolz A. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury. Curr Opin Gastroenterol 2022;38:230-8. [PMID: 35645018 DOI: 10.1097/MOG.0000000000000822] [Reference Citation Analysis]